APA (7th ed.) Citation

Tong, J., Lan, X., Zhang, Z., Liu, Y., Sun, D., Wang, X., . . . Li, D. (2023). Ferroptosis inhibitor liproxstatin-1 alleviates metabolic dysfunction-associated fatty liver disease in mice. Acta Pharmacologica Sinica, 44(5), 1014-1028. https://doi.org/10.1038/s41401-022-01010-5

Chicago Style (17th ed.) Citation

Tong, Jie, et al. "Ferroptosis Inhibitor Liproxstatin-1 Alleviates Metabolic Dysfunction-associated Fatty Liver Disease in Mice." Acta Pharmacologica Sinica 44, no. 5 (2023): 1014-1028. https://doi.org/10.1038/s41401-022-01010-5.

MLA (9th ed.) Citation

Tong, Jie, et al. "Ferroptosis Inhibitor Liproxstatin-1 Alleviates Metabolic Dysfunction-associated Fatty Liver Disease in Mice." Acta Pharmacologica Sinica, vol. 44, no. 5, 2023, pp. 1014-1028, https://doi.org/10.1038/s41401-022-01010-5.